文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

长时间使用神经肌肉阻滞剂与内科ICU机械通气患者远期死亡率升高相关:一项回顾性队列研究

Prolonged use of neuromuscular blocking agents is associated with increased long-term mortality in mechanically ventilated medical ICU patients: a retrospective cohort study.
PubMed 文献 · J Intensive Care · 2023-11-17
一句话结论内科ICU机械通气患者使用神经肌肉阻滞剂超过48小时与远期死亡率独立相关(调整HR 1.261,95%CI 1.07-1.486)。

该回顾性队列研究利用2015—2019年台中荣民总医院重症数据库及台湾死亡登记资料,纳入5709例机械通气患者(男性63.8%,平均年龄67.8±15.8岁),一年死亡率为48.3%(2755/5709)。死亡组年龄、APACHE II评分、通气时间及神经肌肉阻滞剂使用超过48小时的比例均高于存活组。调整年龄、性别及相关协变量后,使用神经肌肉阻滞剂超过48小时与死亡风险升高独立相关(调整HR 1.261;95%CI 1.07-1.486),该关联在Charlson共病指数≥3分的患者中趋于更强。作者认为需进一步研究验证。

要点

  • 在5709例内科ICU机械通气患者中,使用神经肌肉阻滞剂超过48小时与一年死亡风险升高独立相关(调整HR 1.261;95%CI 1.07-1.486)。
  • 死亡组使用神经肌肉阻滞剂超过48小时的比例为11.1%,高于存活组的7.8%(p<0.001)。
  • 死亡组年龄70.4±14.9岁 vs 存活组65.4±16.3岁(p<0.001),APACHE II评分28.0±6.2 vs 24.7±6.5(p<0.001)。
  • 死亡组通气时间12.6±10.6天 vs 存活组7.8±8.5天(p<0.001)。
  • 该关联在Charlson共病指数≥3分的患者中趋于更强。

适用人群与场景

  • 2015—2019年台中荣民总医院(台湾中部转诊中心)重症数据库中接受机械通气的重症患者,共5709例纳入分析。
  • 男性占63.8%,平均年龄67.8±15.8岁。

研究设计与关键结果

  • 研究类型:回顾性队列研究,使用2015—2019年台中荣民总医院重症数据库及台湾全国死亡登记资料。
  • 共5709例机械通气患者纳入分析,男性63.8%,平均年龄67.8±15.8岁,一年死亡率48.3%(2755/5709)。
  • 死亡组与存活组比较:年龄70.4±14.9岁 vs 65.4±16.3岁(p<0.001);APACHE II评分28.0±6.2 vs 24.7±6.5(p<0.001);通气时间12.6±10.6天 vs 7.8±8.5天(p<0.001);使用神经肌肉阻滞剂超过48小时的比例11.1% vs 7.8%(p<0.001)。
  • 调整年龄、性别及相关协变量后,使用神经肌肉阻滞剂超过48小时与死亡风险升高独立相关(调整HR 1.261;95%CI 1.07-1.486)。
  • 效应修饰分析显示,该关联在Charlson共病指数≥3分的患者中趋于更强。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性;作者在结论中提出需进一步研究验证该发现。

对床旁实践的改变

  • 作者认为,长时间使用神经肌肉阻滞剂与需要机械通气的重症患者远期死亡率升高相关,需进一步研究验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Neuromuscular blockade agents (NMBAs) can be used to facilitate mechanical ventilation in critically ill patients. Accumulating evidence has shown that NMBAs may be associated with intensive care unit (ICU)-acquired weakness and poor outcomes. However, the long-term impact of NMBAs on mortality is still unclear.

METHODS: We conducted a retrospective analysis using the 2015-2019 critical care databases at Taichung Veterans General Hospital, a referral center in central Taiwan, as well as the Taiwan nationwide death registry profile.

RESULTS: A total of 5709 ventilated patients were eligible for further analysis, with 63.8% of them were male. The mean age of enrolled subjects was 67.8 ± 15.8 years, and the one-year mortality was 48.3% (2755/5709). Compared with the survivors, the non-survivors had a higher age (70.4 ± 14.9 vs 65.4 ± 16.3, p < 0.001), Acute Physiology and Chronic Health Evaluation II score (28.0 ± 6.2 vs 24.7 ± 6.5, p < 0.001), a longer duration of ventilator use (12.6 ± 10.6 days vs 7.8 ± 8.5 days, p < 0.001), and were more likely to receive NMBAs for longer than 48 h (11.1% vs 7.8%, p < 0.001). After adjusting for age, sex, and relevant covariates, the use of NMBAs for longer than 48 h was found to be independently associated with an increased risk of mortality (adjusted HR: 1.261; 95% CI: 1.07-1.486). The analysis of effect modification revealed that this association was tended to be strong in patients with a Charlson Comorbidity Index of 3 or higher.

CONCLUSIONS: Our study demonstrated that prolonged use of NMBAs was associated with an increased risk of long-term mortality in critically ill patients requiring mechanical ventilation. Further studies are needed to validate our findings.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Lin C, Chao WC, Pai KC, et al. Prolonged use of neuromuscular blocking agents is associated with increased long-term mortality in mechanically ventilated medical ICU patients: a retrospective cohort study. J Intensive Care. 2023. PMID: 37978572. doi:10.1186/s40560-023-00696-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。